Abstract
Attempts to improve the production of (heterologous) proteins in yeast cells have, to date, focused almost exclusively on increasing the transcriptional yield of the heterologous gene by raising the number of gene copies per cell, and/or putting the gene under the control of a strong homologous promoter. However, the cellular level of translatable mRNA is a function of the rate at which it is produced and the rate at which it is removed - or at least inactivated - by nucleolytic degradation. Recently, considerable progress has been made in unravelling the mechanism of mRNA decay in yeast cells and in identifying both the cis-acting stability determinants and the trans-acting factors involved in this process. This knowledge can be used as the basis for rational engineering of a given transcript to modulate its metabolic stability, and thus its cellular level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
